Breaking News

Rubicon Genomics, Velesco in Clinical Diagnostics Pact

Velesco to manufacture TransPLEX diagnostic kits

Author Image

By: Tim Wright

Editor-in-Chief, Contract Pharma

Rubicon Genomics has selected Velesco Pharmaceutical Services to manufacture the TransPLEX kits for use with Agendia’s breast cancer diagnostics. Agendia is using Rubicon’s kits for analysis of FFPE (formalin-fixed, paraffin-embedded) patient samples for use with its Symphony breast cancer diagnostics. Rubicon’s TransPLEX RNA kits and GenomePLEX DNA kits are members of its OmniPLEX family of amplification technologies that are designed to deliver sufficient quantities of high quality nucleic ac...

Continue reading this story and get 24/7 access to Contract Pharma for FREE


Already a subscriber? Sign in

Keep Up With Our Content. Subscribe To Contract Pharma Newsletters